Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Novoseven (Activated Factor VII therapeutic use).php on line 2
Novoseven (Activated Factor VII therapeutic use)
LE WE PMID CA
Novoseven (Activated Factor VII therapeutic use)3511Novoseven (Aktivierter Faktor VII zum Blutstillen)

CNS (Intracerebral bleeding)

Hemophilia

Liver (Resection)

Liver (Transplantation)

Novoseven (Activated Factor VII therapeutic use)

2008  
1
Recombinant activated factor VIIa for the treatment of bleeding in major abdominal surgery including vascular and urological surgery: a review and meta-analysis of published data.
[18279513] Crit Care 12(1): R14 (2008)
2006  
2
Early recombinant activated factor VII for intracerebral hemorrhage reduced hematoma growth and mortality, while improving functional outcomes.
[16420665] Crit Care 10(1): 304 (2006)
2002  
3
Towards evidence based emergency medicine: best BETs from Manchester Royal Infirmary. Factor VIIa for intractable blood loss in trauma.
[12421790] Emerg Med J 19(6): 556-7 (2002)
2002  
4
Recombinant activated factor VII: its mechanism of action and role in the control of hemorrhage.
[12546000] Can J Anaesth 49(10): S7-14 (2002)
2009  
5
The use of recombinant activated factor VII in platelet disorders: a critical review of the literature.
[19290076] Blood Transfus 7(1): 24-8 (2009)
2009  
6
Clinical guidelines and off-license recombinant activated factor VII: content, use, and association with patient outcomes.
[19804534] J Thromb Haemost 7(12): 2016-22 (2009)
2006  
7
Potential role of recombinant factor FVIIa in prophylaxis in severe hemophilia patients with inhibitors.
[16907841] J Thromb Haemost 4(11): 2498-500 (2006)
2005  
8
Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force.
[15842347] J Thromb Haemost 3(4): 640-8 (2005)
2004  
9
Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors.
[15140125] J Thromb Haemost 2(6): 899-909 (2004)
2010  
10
Thromboembolic events with recombinant activated factor VII in spontaneous intracerebral hemorrhage: results from the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial.
[19959538] Stroke 41(1): 48-53 (2010)
2010  
11
Recombinant factor VIIa: an assessment of evidence regarding its efficacy and safety in the off-label setting.
[21239786] Hematology Am Soc Hematol Educ Program 2010(-): 153-9 (2010)
2011  
12
Prophylactic activated recombinant factor VII in liver resection and liver transplantation: systematic review and meta-analysis.
[21818342] PLoS One 6(7): e22581 (2011)
2006  
13
Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding--a European perspective.
[16919168] Crit Care 10(4): R120 (2006)
2007  
14
Safety and efficiency of recombinant activated factor VII in postcardiotomy massive hemorrhage.
[17703260] Can J Cardiol 23(10): 809-13 (2007)
2011  
15
Low-dose recombinant factor VIIa for massive bleeding: a single centre observational cohort study with 73 patients.
[21735365] Swiss Med Wkly 141(-): w13213 (2011)
2004  
16
The potential use of recombinant activated factor VII in trauma and surgery.
[15116814] Scand J Surg 93(1): 17-23 (2004)
2005  
17
Is recombinant FVIIa the magic bullet in the treatment of major bleeding?
[15814804] Br J Anaesth 94(5): 553-5 (2005)
2010  
18
Evidence supporting the use of recombinant activated factor VII in congenital bleeding disorders.
[20689697] Drug Des Devel Ther 4(-): 107-16 (2010)
2011  
19
Current difficulties and recent advances in bypass therapy for the management of hemophilia with inhibitors: a new and practical formulation of recombinant factor VIIa.
[21625417] Drug Des Devel Ther 5(-): 275-82 (2011)
2008  
20
Efficacy and safety of recombinant activated factor vii in major surgical procedures: systematic review and meta-analysis of randomized clinical trials.
[18347278] Arch Surg 143(3): 296-304; discussion 304 (2008)
2005  
21
Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage.
[16159073] Neurocrit Care 2(3): 263-7 (2005)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Novoseven (Activated Factor VII therapeutic use).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Novoseven (Activated Factor VII therapeutic use).php on line 92